2004•NeurologyRequires access

Levetiracetam in progressive myoclonic epilepsy

C. Crest, Sébastien Dupont, Éric Leguern, Christine Adam, Michel Baulac

Abstract

The authors conducted an open study of levetiracetam as add-on therapy in nine patients with well-defined progressive myoclonic epilepsies and refractory myoclonus. Myoclonus was evaluated semiquantitatively (territory, intensity, daily living activities). Five patients had improvement of their myoclonus score. Levetiracetam may benefit myoclonus in progressive myoclonic epilepsy.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 68 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Levetiracetam, Progressive myoclonus epilepsy, Myoclonus, Medicine, Refractory (planetary science), Epilepsy, Piracetam, Myoclonic epilepsy